Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
US9073963B2 · kind B2 · utility
0Cited by
17References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 15, 2009 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Jun 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions which are useful for inhibiting prostaglandin F2α receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.